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PERCUTANEOUS 
TRANSLUMINAL CORONARY 
ANGIOPLASTY FAILURES IN 
PATIENTS WITH 
MULTIVESSEL DISEASE 
Is there an increased risk? 
In recent years, there has been a nationwide trend toward performing 
percutaneous transluminal coronary angioplasty in patients with multivessel 
coronary artery disease. The clinical course of 57 consecutive patients who 
required emergency first-time coronary artery bypass grafting operations were 
reviewed to assess for difference in outcome between the 28 patients (49%) with 
single:vessel disease and the 29 patients (51%) with multivessel disease. The 
two groups were similar in preoperative characteristics except for a higher 
proportion of chronic obstructive pulmonary disease in the patients with 
multivessel disease (p = 0.03). Twice as many patients with multivessel disease 
were in shock (single-vessel disease = 4 [14%], mnltivessel disease = 8 [28%], 
p = not significant) en route to the operating room and significantly more 
patients with multi~essel disease required on-going cardiopulmonary resusci- 
tation (single-vessel disease = 0 [0%], multivessel disease = 5 [17%], p = 
0.03). Significantly more coronary artery bypass grafts were placed in the 
patients with multivessel disease (single-vessel disease = 1.5 - 0.6, multivessel 
disease = 2.9 __. 0.7,p < 0.01), which required longer aortic clamping time (p = 
0.02) and cardiopulmonary b pass time (p < 0.01). There were seven postop- 
erative deaths; all but one occurred in patients with multivessel disease 
(single-vessel disease = 1 [4%], multivessel disease = 6 [21%], p = 0.05). 
According to multivariate analysis, incremental risk factors of mortality were 
preoperative shock (p< 0.01), urgent or emergency percutaneous translumi- 
nal coronary angioplasty (p = 0.06), and multivessel disease (17 = 0.12). 
Despite a similar incidence of myocardial infarction (single-vessel disease = 8 
[29%], multivessel disease = 12 [41%], p = not significant), patients with 
multivessel disease had a higher incidence of cardiac morbidity (single-vessel 
disease = 4 [14%], multivessel disease = 11 [38%],p = 0.04) and noncardiac 
morbidity (single-vessel disease = 4 [14%], multivessel disease = 12 [41%], 
p = 0.02). By multivariate analysis, incremental risk factors of morbidity were 
preoperative shock (p < 0.01), multivessel disease (p = 0.02), and ejection 
fraction < 50% (p = 0.07). In the subset of patients with multivessel disease, 
preoperative shock, ejection fraction < 50, and an age of 60 years or greater 
were associated with higher morbidity and mortality. In conclusion, the risk of 
percutaneous transluminal coronary angioplasty failure is considerably higher 
in patients with multivessel disease. In certain subsets of patients with multivessel 
disease, coronary artery bypass grafting would be a safer procedure when 
compared with percutaneous translmninal coronary angioplasty for initial myo- 
cardial revascularization. (J THORAC CARDIOVASC SURG 1995;110:214-23) 
Nan Wang, MD, Steven R. Gundry, MD, Glen Van Arsdell, MD, 
Anees J. Razzouk, MD, Arthur C, Hill, MD, Matts Sjolander, PhD, 
Kerry A. Cavazos, RN, CCRN, Jill M. Brewer, RN, 
Edwin E. Vyhmeister, MD, and Leonard L. Bailey, MD, Loma Linda, Calif. 
From the Division of Cardiothoracic Surgery, Department of 
Surgery, Loma Linda University Medical Center, Loma 
Linda, Calif. 
Read at the'Twentieth Annual Meeting of The Western Thoracic 
Surgical Association, Olympic Valley, Calif., June 22-25, 1994. 
Address for reprints: Nan Wang, MD, Assistant Professor of 
Surgery, Division of Cardiothoracic Surgery, Loma Linda 
University Medical Center, Department of Surgery, 11234 
Anderson St., Loma Linda, CA 92354. 
I n the past decade, the number of percutaneous transluminal angioplasty (PTCA) procedures per- 
formed has escalated dramatically. An estimated 
300,000 PTCA procedures were done in 1990.1 The 
broadening of the clinical indications for PTCA is 
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the most likely cause for such a trend. A notable 
change in the PTCA patient profile is the substantial 
increase in the proport ion of  patients with multives 
sel coronary artery disease (MVD). 1' 2 According to 
the most recent National Heart, Lung, and Blood 
Institute PTCA Registry, over 50% of the patients 
with PTCA had MVD. 2 Bell and associates 3 re- 
ported even a higher percentage of their patients 
(83%) as having MVD. The overall risk of  PTCA 
has already been affected by such a change in PTCA 
practice. The patients with MVD were found to 
have a significantly higher mortality rate (one vessel 
= 0.2% versus two vessels = 0.9% versus three 
vessels = 2.8%). 2 Ellis and associates 4 also reported 
an increase in in-hospital cardiac deaths in the 
patients with MVD in the setting of acute vessel 
closure from PTCA. Do  these findings, in fact, also 
affect the risk of emergency coronary artery bypass 
grafting (CABG) in the event of PTCA failure? 
Antecdotally, we have noted an alarming trend of 
more patients arriving to the operating room in 
moribund condition after PTCA failures. We have 
also observed that these patients were more likely to 
have MVD. In their moribund condition, these 
patients had fared poorly from emergency CABG 
despite having relatively low preoperative risks be- 
fore PTCA. This study is therefore undertaken to 
determine whether MVD indeed increases the risk 
of emergency CABG after PTCA failure and 
whether certain MVD patient subsets have a pro- 
hibitively high risk of PTCA failure, thus making 
them better CABG candidates. 
Patients and methods 
Patient population. Between June 1, 1988, and January 
31, 1994, a total of 2307 PTCA procedures were per- 
formed in 1866 patients at Loma Linda University Med- 
ical Center. From this registry, 60 cases (2.6% of" the 
PTCA cases) were identified as PTCA failures requiring 
emergency CABG operations because of acute vessel 
closure, thrombosis, or dissection. These cases were true 
emergencies in that all patients had clinical evidence of 
on-going ischemia such as angina or electrocardiogram 
changes. The majority of the patients (93%) were trans- 
ferred from the PTCA suite to the operating room for 
immediate CABG. Four patients had delayed onset of 
isehemia nd required emergency CABG within 24 hours 
of PTCA. 
The perioperative course of these 60 patients were 
reviewed. Three patients were excluded from the study on 
the basis of having had prior CABG (two patients) and 
untreated severe mitral valve disease (one patient). Thus, 
this study corisisted of the remaining 57 patients who had 
coronary artery disease as their only cardiac pathologic 
condition ,and CABG as their first operation. These 
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patients were divided into two groups: 28 patients (49%) 
with single-vessel disease (SVD), and 29 patients (51%) 
with MVD. This proportion resembled the proportion of 
the entire population in the PTCA R~gistry (SVD = 48%, 
MVD = 52%). 
Operative strategy. All PTCA procedures had prear- 
ranged surgical backup, and the level of support was 
determined according to the recommendation of the 
American College of Cardiology and American Heart 
Association. 1 Essentially all patients had level 2 support, 
and none of these patients met the criteria for level 3 
support. In the event of acute vessel closure, an attempt 
was made by the cardiologist to reverse acute myocardial 
ischemia by inserting a perfusion catheter across the site 
of occlusion. Stenting of the coronary artery was at- 
tempted in two patients. Only recently were intraaortic 
balloon pumps (IABP) inserted on a regular basis in the 
patients with unstable conditions. 
On arrival to the operating room, all patients except for 
three were supported with cardiopulmonary b pass via 
median sternotomy as soon as possible. In three patients, 
single-vessel CABGs were performed without cardiopul- 
monary bypass. In patients with a suitable left anterior 
descending target, the left internal thoracic artery was 
taken down as a conduit in the patients with relatively 
stable conditions. Frequently, dissection of the left inter- 
nal thoracic artery was done after commencement of
cardiopulmonary b pass. 
The method of myocardial protection varied according 
to the surgeon's preference. There were primarily three 
modes of myocardial protection: c01d, intermittent, ante- 
grade or'retrograde, oxygenated crystalloid cardioplegic so- 
lution; cold, intermittent, retrograde, blood cardioplegic 
solution; or warm, continuous, retrograde, blood cardiople- 
gic solution. Inotropes were used at the end of the operation 
only when deemed necessary. In patients with severely 
compromised postoperative hemodynamics, IABP or ven- 
tricular assist devices (centrifugal pumps) were inserted and 
used. 
Outcome analysis. The postoperative mortality and 
morbidity of the two groups of patients were analyzed and 
compared. Mortality was defined as any in-hospital death 
or death within 30 days of CABG. Morbidity was defined 
according to the major complication types in the National 
Cardiac Surgery Database as proposed by the Society of 
Thoracic Surgeons. Any complication was further catego- 
rized into either cardiac or noncardiac omplication. 
Myocardial infarction was also examined as an end-point 
and was defined as having any new finding on serial 
electrocardiogram or postoperative chocardiography 
subsequent to PTCA failure. 
Univariate comparisons between the two groups of 
patients were performed with the use of the Fisher exact 
or the ~ analysis for discrete variables and unpaired 
Student's t test for continuous data. Certain continuous 
data were converted into discrete proportions by prede- 
termined cut points, and these discrete proportions were 
retested with X 2 analysis. Further analysis of morbidity 
and mortality was carried out with the use of a multivari- 
ate model. All preoperative or operative variables (Ap- 
pendix A) found to be of significance (p < 0.05) or 
marginal significance (p < 0.10) with the univariate 
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Table I. Patient profiles 
SVD MVD 
variable (n = 28) (n = 29) p Value 
Age (yr) 61.i + 9.9 60.2 +_ 7.0 NS 
Weight (kg) 74.1 _+ 11.0 80.4 _+ 9.6 NS 
Ejection fraction (%) 56.5 _+ 9.0 58.5 -+ 11.7 NS 
Male 16 (57%) 21 (72%) NS 
Smoker 11 (39%) 13 (45%) NS 
Obesity 6 (21%) 4 (14%) NS 
HCL 14 (50%) 15 (52%) NS 
DM 8 (29%) 11 (38%) NS 
HTN 19 (68%) 15 (52%) NS 
COPD 0 (0%) 5 (17%) 0.03 
PVD 0 (0%) 1 (3%) NS 
CHF 1 (4%) 2 (7%) NS 
MI 14 (50%) 12 (41%) NS 
NS, Not significant; HCL, hypercholesterolemia; DM, diabetes mellitus; 
HTN,, hypertension; COPD, chronic obstructive pulmonary disease; PVD, 
peripheral vascular disease; CHF, congestive h art failure; M/, myocardial 
infarction. 
Table II. Comparison of PTCA demographic data 
and outcomes 
SVD MVD 
Variable (n = 28) (n = 29) p Value 
E/U PTCA 11 (39%) 11 (38%) NS 
Multiple PTCA 0 (0%) 8 (28%) 0.01 
Prior PTCA 5 (18%) 2 (7%) NS 
Add device 6 (21%) 2 (7%) NS 
Culprit vessel 
LAD 16 (57%) 18 (62%) NS 
RCA 12 (43%) 10 (35%) NS 
Cx o (0%) 1 (3%) NS 
Shock 4 (14%) 8 (28%) NS 
CPR 0 (0%) 5 (17%), 0.03 
IABP/CPS 0 (0%) 4 (14%) 0.06 
E/U, Emergency or urgent; NS, not significant; device, stent, arthrectomy, 
or laser procedure; LAD, left anterior descending artery; RCA, right 
coronary artery; Cx; circumflex artery; CPR, cardiopulmonary resuscita- 
tion; IABP, intraaortic balloon pump; CPS, percutaneous cardiopulmonary 
support. 
method were entered into a logistic regression analysis for 
morbidity and mortality. This analysis was performed to 
assess the independent contributions of th e multiple vari- 
ables to the development of postoperative morbidity and 
mortality. All calculations were performed with the SPSS, 
version 4.0:2 statistica! program (Statistical Package for 
the Social Sciences, Chicago, Ill.) for the Macintosh 
computer (Apple Computer, Cupertino, Calif.). 
Results 
Patient profile. The preoperative characteristics 
of the two groups of patients are shown on Table I. 
Both groups consisted of patients with a mean age 
close to 60 years with essentially normal ejection 
fractions. Although not significant, diabetes mellitus 
was more prevalent in the MVD group, and the 
female gender was more prevalent in the SVD 
group. The two groups were comparable except for 
a significantly increased proportion of chronic ob- 
structive pulmonary disease in the MVD group. 
However, by univariate analysis, Chronic obstructive 
pulmonary disease did not significantly influence the 
postoperative outcome. 
Almost40% of each group of patients underwent 
PTCA on an urgent or emergency basis (Table II). 
PTCA of more than one coronary artery distribution 
was performed in 28% of the patients with MVD. 
Additional devices uch as stents, arthrectomy cath- 
eters, or laser devices were applied more frequently 
to the SVD group. 
In only one patient was the culprit vessel respon- 
sible for the PTCA failure in the circumflex artery 
distribution. Otherwise, the left anterior descending 
artery outnumbered the right coronary artery as the 
culprit vessel by a ratio of 2:1. The type of culprit 
vessel did not significant affect he subsequent clin- 
ical outcome. Although not significant, more pa- 
tients in shock from acute vessel occlusion were in 
the MVD group. Over half of these patients re- 
quired cardiopulmonary resuscitation e route to the 
operating room. No one in the SVD group required 
cardiopulmonary resuscitation. Four patients with 
MVD required preoperative IABP for hemody- 
namic stabilization. One of these patients also re- 
quired percutaneous cardiopulmonary support in 
the PTCA suite. No patient with SVD required such 
support. 
Significantly more bypass grafts were used in the 
patients with MVD (Table III), thus cardiopulmo- 
nary bypass time and aortic clamping time were 
necessarily longer. Cardioplegia was not used in five 
patients. Three of these patients had a single-vessel 
coronary bypass performed without cardiopulmo- 
nary bypass; and the other two patients were revas- 
cularized while supported with cardiopulmonary 
bypass without damping the aorta. The majority of 
the patients (91%) had one of three modes of 
myocardial protection. Although a difference in the 
method of myocardial protection was apparent in 
the patients with SVD versus,those with MVD, the 
mode of myocardial protection did not contribute 
significantly to the postoperative outcome by univa- 
riate analysis. 
Mortality. Despite relatively low preoperative 
risks before PTCA (Table I), the overall mortality in 
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Table III. Comparison of CABG demographic data 
and outcomes 
SVD MVD 
Variable (n = 28) (n = 29) p Value 
Grafts (No.) 1.5 -4- 0.6 2.9 _+ 0.7 <0.01 
LITA/LAD 5/15 (33%) 8/23 (35%) NS 
CPB (min) 87.0 _+ 26.0 118.9 _+ 37.8 0.02 
Xclamp (min) 42.5 _+ 14.6 67.3 _+ 19.4 <0.01 
Cardioplegia 
None 4 (14%) 1 (3%) NS 
Cold crystalloid 6 (21%) 13 (45%) 0.06 
Cold blood 16 (57%) 9 (31%) NS 
Warm blood 1 (4%) 6 (21%) NS 
Inotrope 11 (39%) 13 (45%) NS 
IABP 2 (7%) 5 (17%) NS 
VAD 1 (4%) 3 (10%) NS 
LITA, Left internal thoracic artery; LAD, left anterior descending artery; 
NS, not significant; CPB, cardiopulmonary bypass time; Xclamp, cross- 
clamp time; IABP, intraaortic balloon pump; VAD, ventricular assist 
device. 
this series was 11.7%, which was considerably higher 
than the mortality rate of primary CABG operations 
performed during the same period of time (2% to 
3%) at the same institution, However, all except 
for one death occurred in patients with MVD. 
This difference in ,mortality was also significant 
(MVD = 21%, SVD = 4%,p = 0.05) (Table IV). 
Of the six deaths in the patients with MVD, one 
patient had a prolonged PTCA attempt of both 
the right coronary artery and the left anterior 
descending artery. After successful CABG; he had 
sudden cardiac arrest and could not be resusci- 
tated. Autopsy showed a large myocardial infarc- 
tion with patent grafts. The remaining five pa- 
tients were brought to the operating room in 
shock; three had on-going cardiopulmonary resus- 
citation. An IABP was inserted in one patient 
before the operation in the PTCA suite, but it was 
ineffective because the patient was in full arrest. 
Four of these five patients continued in a low 
cardiac output state after the operation and died 
shortly thereafter. The final patient died of mul- 
tisystem organ failure approximately 1week after 
the CABG operation. There was only one death in 
the SVD patient group. This patient had a pro- 
longed attempt at angioplasty of a complex right 
coronary artery lesion. She was deemed a poor 
surgical candidate because of her age and accom- 
panying renal failure from polycystic kidney dis- 
ease. Prolonged ischemia accompanied the multi- 
ple attempts at opening the acutely occluded right 
coronary artery. She died of sepsis and multiple 
organ system failure a week after the operation. 
Table IV. Mortality and morbidity 
SVD MVD 
Variable (n = 28) (n = 29) p Value 
Mortality 1 (4%) 6 (21%) 0.05 
Cardiac morbidity 4 (14%) 11 (38%) 0.04 
Low CO 3 (11%) 9 (31%) 0.06 
Cardiac arrest 3 (11%) 7 (24%) NS 
IABP 2 (7%) 5 (17%) NS 
LVAD 1 (4%) 3 (10%) NS 
Heart block 0 (0%) 1 (3%) NS 
Noncardiac morbidity 4 (14%) 12 (41%) 0.02 
Bleeding 1 (4%) 6 (21%) 0.05 
Infection/sepsis 2 (7%) 4 (14%) NS 
Stroke 2 (7%) 4 (14%) NS 
Ventilator depen- 3 (11%) 7 (24%) NS 
dency 
ARF 2 (7%) 3 (10%) NS 
GI complication 3 (11%) 4 (14%) NS 
Vascular complica- 1 (4%) 1 (3%) NS 
tion 
Myocardial infarction 8(29%) 12 (41%) NS 
LOS (days) 7.1 _+ 3.0 10.3 _+ 5.4 0.07 
CO, Cardiac output; NS, not significant;/ABP, intraaortic balloon pump; 
LVAD, left ventricular assist device; ARF, acute renal failure; G/, gastro- 
inteStinal; LOS, length of stay (postoperative). 
Table V. Univariate predictors of mortality 
Variable Deaths p Value Odds ratio 
Age 
<60 years 1/28 (3.6%) 0.05 7.0 
-->60 years 6/29 (20.7%) 
EF 
-->50% 3/41 (7.3%) 0.09 4.2 
<50% 4/16 (25.0%) 
PTCA 
E1 2/35 (5.7%) 0.07 4.6 
Ur/Em, 5/22 (22.7%) 
Shock 
No 2/45 (4.4%) 0.01 15.4 
Yes 5/12 (41.7%) 
SVD 1/28 (3.6%) 0.05 7.0 
MVD 6/29 (20.7%) 
EF, Ejection fraction; El, elective; Ur/Em, urgent or emergency; SVD, 
single-vessel disease; MVD, multivessel disease. 
Considerable myocardial damage was evident at 
autopsy in all patients who had died. This finding 
was consistent with the clinical evidence of severe 
myocardial dysfunction in these patients. 
According to univariate analysis (Table V), the 
increase in risk of mortality was significant in these 
patients: age > 60 years (p = 0.04), preoperative 
shock (p < 0.01), MVD (p = 0.05); the increase in 
risk was mildly significant in these patients: ejection 
fraction < 50% (p = 0.08), urgent or emergency 
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Table VI. Multivariate predictors of morbidity and 
mortality 
Variable Events p Value Odds ratio 
Mortality 
No shock 2/95 (4.45%) <0.01 20.4 
Shock 5/12 (41.7%) 
PTCA-E1 2/35 (5.7%) 0.06 7.2 
PTCA- Ur/Em 5/22 (22.7%) 
SVD 1/28 (3.6%) 0.12 5.9 
MVD 6/29 (20.7%) 
Morbidity 
No shock 9/45 (20.0%) <0.01 12.5 
Shock 9/12 (75.0%) 
SVD 4/28 (14.3%) 0.02 8.6 
MVD 14/29 (48.3%) 
EF --> 50% 9/41 (22.0%) 0.07 4.1 
EF < 50% 9/16 (56.3%) 
El, Elective; Ur/Em, urgent or emergency; EF, ejection fraction. 
PTCA (p = 0.09). According to multivariate analysis 
(Table VI), the independent predictors of mortality 
were as follows: preoperative shock (p < 0.01), 
urgent or emergency PTCA (p = 0:06), MVD (p = 
0.12). Because of the small number of outcome 
events (deaths), MVD was only marginally signifi- 
cant as an independent predictor of mortality. 
Although preoperative shock was the single most 
important predictor of mortality, this variable had 
no effect on mortality in the SVD patient subset. Of 
the 12 patients with preoperative shock (SVD = 4, 
MVD = 8), none of the four patients with SVD 
required cardiopulmonary resuscitation or died in 
the postoperative p riod. But of the eight patients 
with MVD, five (68%) required cardiopulmonary 
resuscitation and four (50%) ultimately died. Pre- 
operative shock, therefore, increased the risk of 
mortality primarily in the patients with MVD (p < 
0.01). The other risk factors for mortality in the 
MVD patient subset were ejection fraction < 50% 
(p = 0.05) and age -> 60 years (p = 0,08). 
Morbidity. As shown in Table IV, the incidences 
of postoperative cardiac morbidity (SVD = 14%, 
MVD = 38%, p = 0.04) and noncardiac morbidity 
(SVD = 14%, MVD = 41%, p = 0.02) were 
significantly higher in the patients with MVD. In 
fact, only 4 of the 28 patients with SVD had any 
morbidity at all. In the patients with MVD, almost 
one third had evidence of low cardiac output in the 
postoperative period, and almost a quarter had 
cardiac arrest either from arrhythmias or ischemia 
after the operation. 
Centrifugal pumps were used as left ventricular 
assist devices in four patients. Only one patient 
survived, and this patient had SVD. The rates of 
postoperative myocardial infarction were similar in 
both groups (SVD = 29%, MVD = 41%), but the 
complications of perioperative myocardial infarc- 
tion such as low cardiac output or cardiac arrest 
events were greater in the patients with MVD, 
suggesting more profound myocardial damage in 
the patients with MVD. Accompanying the increase 
in morbidity in the patients with MVD, the length of 
hospital stay was also increased (SVD = 7.0 _+ 3.0 
days, MVD = 10.3 + 5.4 days, p = 0.07). 
According to multivariate analysis (Table VI), the 
independent predictors of morbidity were as fol- 
lows: preoperative shock (p < 0.01), MVD (p = 
0.02), and ejection fraction < 50% (p = 0.07). MVD 
was therefore a significant independent risk factor 
of morbidity. 
As expected, preoperative shock increased the 
cardiac and noncardiac morbidity in both SVD and 
MVD patient subsets. No other predictors of mor- 
bidity were found in the SVD patient subset. But in 
the MVD patient subset, other isk factors were age 
-> 60 years for cardiac morbidity (p = 0.03) and an 
ejection fraction < 50 for noncardiac morbidity (p = 
'0.02). 
Discussion 
Over the past decade, the number of PTCA 
procedures performed in the United States has 
increased ten-fold. 5 As cardiologists have gained 
greater PTCA experience, the clinical indications 
for PTCA have broadened considerably. When 
PTCA was introduced in 1977, the procedure was 
designed to treat patients with SVD with discrete, 
proximal, noncalcified, subtotally occlusive lesions. 6 
By 1980, a substantial proportion (40%) of patients 
treated with PTCA had MVD. 7 Currently, more 
patients with MVD (50% to 60%) 1' 2 than patients 
with SVD undergo PTCA daily. As PTCA emerges 
to become the preferred method of achieving myo- 
cardial revascularization in patients with MVD, 3' s, 9 
there is mounting evidence that the overall outcome 
is not as favorable 2' 10 and that the potential for 
serious complications i greater, a'H Furthermore, 
O'Keefe and associates 9 found that a considerable 
higher proportion of patients with MVD (16%) 
required early CABG operations after PTCA. Sim- 
ilarly, in the Heart, Lung, and Blood Institute PTCA 
Registry, CABG operations were more frequently 
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required (6% to 8%) in the patients with MVD; 
approximately half of these operations were done on 
an urgent or emergency basis. 
Our experience over the past 6 years reflected a
similar trend. MVD was present in over 50% of our 
patients undergoing PTCA. Although PTCA fail- 
ures requiring emergency CABG had occurred just 
as often in the SVD as in the MVD patient subsets, 
we found the operative complications to be signifi- 
cantly greater in the patients with MVD. Only one 
of the seven postoperative deaths occurred in a 
patient with SVD. The overall mortality in this 
series was 11.7%, which is comparable with that of 
other reports12-18; but the mortality in patients with 
MVD was considerably higher (SVD = 3.6%, MVD 
= 20.5%,p = 0.05). Our data corroborated those of 
other studies 15' 18,19 which also showed an increased 
risk of emergency CABG for PTCA failure when 
MVD was present. 
Several factors contributed to the relatively high 
mortality in the patients with MVD in this series. As 
several investigators had found, 12' 13,17 operative 
mortality for PTCA failures had not changed signif- 
icantly over the past decade, despite advances in 
surgical technique and myocardial protection. Be- 
cause of the change in patient profile, Boylan and 
associates 13 had found the operative mortality to be 
even higher. Talley 19 and Connor 2~ and their asso- 
ciates reported exceptionally low mortality figures, 
but the patient populations in their series were 
different. They had included the patients with more 
stable conditions who had essentially elective CABG 
operations within several days of their PTCA fail- 
ures. In this series, all but four patients were trans- 
ferred directly to the operating room from the 
PTCA suite because of unstable ischemic or hemo- 
dynamic findings. The remaining four patients also 
required true emergency CABG operatiofis for 
acute onset of ischemia within 24 hours of PTCA 
failures. Less urgent CABG candidates were not 
included in the study. Furthermore, a significant 
proportion of patients (9 of 23, 31.0%) had three- 
vessel disease in this series. But probably the most 
important reason for the high mortality in the 
patients with MVD was the presence of severe 
hemodynamic instability in over one third of these 
patients after PTCA failure. 
Cardiogeni c shock after PTCA failure was a def- 
inite incremental risk factor for postoperative mor- 
tality in many large series. 13' 14, 16, 18 By multivariate 
analysis, cardiogenic shock was the single most 
significant (p < 0.01) independent risk factor for 
mortality in the present study. However, the impact 
of preoperative hemodynamic instability on mortal- 
ity was only evident in the patients with MVD. The 
overall incidence of cardiogenic shock immediately 
after PTCA failure was 20% (SVD = 14.3%, MVD 
= 27.6%). But none of the four patients with SVD 
with preoperative cardiogenic shock required car- 
diopulmonary esuscitation, and all ultimately sur- 
vived. In contrast, of the eight patients with MVD 
with preoperative cardiogenic shock, five (68%) 
required preoperative cardiopulmonary esuscita- 
tion and half of these patients eventually died. The 
patients with SVD probably had more myocardial 
reserve which would allow for a safer transition from 
the PTCA suite to the operating room even in the 
presence of profound hemodynamic instability. The 
patients with MVD would more likely have a greater 
amount of myocardium atrisk in the event of acute 
vessel closure. It may therefore be important that an 
objective clinical parameter such as the myocardial 
jeopardy index, 21' 22 which has been shown to corre- 
late with postoperative outcome, 4'21-23 be used, 
particularly in the patients with MVD, to better 
stratify their PTCA risk. Patients with MVD and 
high myocardial jeopardy index are probably at a 
greater' risk of cardiogenic shock in the event of 
PTCA failure. The consequence of cardiogenic 
shock in such patients can be catastrophic, as is 
shown in the present study. 
In addition to preoperative shock, other signifi- 
cant or marginally significant risk factors for post- 
operative mortality in the patients with MVD were 
an ejection fraction < 50% (p = 0.05) and age -< 60 
years or older (p = 0.08). These findings are com- 
patible with findings in other series. 16'24 Older 
patients and patients with lower ejection fractions 
have less cardiac and physiologic reserve. They are 
less likely to tolerate an acute vessel closure com- 
plication. Elderly patients with MVD and even a 
mildly impaired left ventricular function are proba- 
bly better served by CABG instead of PTCA. 
According to multivariable analysis, operative 
morbidity was also significantly higher in the pa- 
tients with MVD. Such increases in morbidity in the 
patients with MVD were also observed by other 
investigators. 15'19'25 Greene and associates 15 re- 
ported substantial differences between patients with 
SVD and patients with MVD with regard to inotro- 
pic support for low cardiac output (MVD = 75%, 
SVD = 57%) and IABP requirement (MVD = 
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25%, SVD = 5%). The present series showed a 
similar trend. The overall incidence of low cardiac 
output requiring prolonged inotropic support was 
21%, considerably ower than 24% to 68% reported 
in other studies 14' 15, 24 but was higher in the patients 
with MVD (SVD = 11%, MVD = 31%,p = 0.06). 
Although not significant, the use of IABP was twice 
as high in the patients with MVD (SVD = 7%, 
MVD = 17%). 
The more complicated course of patients with 
MVD may be inferred by comparing the length of 
hospital stay (SVD = 7.1 __ 3.0 days, MVD = 10.3 
-2_ 5.4 days, p = 0.07). A similar difference was also 
noted by Greene and associates 15(SVD = 10.5 -+ 
2.9 days, MVD = 15.0 +_ 9.9 days, p < 0.05). Our 
overall average length of stay compared favorably 
with the results of other series which ranged be- 
tween 12 to 16 days. 12' 14, 15 
On the basis of our findings, we suggest that 
patients with' MVD are at a higher risk for 
postoperative morbidity and mortality in the event 
of PTCA failure. Because more than half of the 
patients undergoing PTCA each day have MVD, it 
is unlikely that cardiologists will alter this practice 
pattern unless the long-term result of CABG is 
found to be far superior to that of PTCA. How- 
ever, our series suggests that greater caution 
should be exercised and selection of patients with 
MVD for PTCA should be more specific. The risk 
of PTCA appears particularly high in these pa- 
tients with MVD: (1) age greater than 60 years, 
(2) ejection fraction less than 50%, and (3) esti- 
mate of a large amount of myocardium at risk in 
the event of acute vessel closure. The patient with 
MVD with one or more of these characteristics 
should receive formal surgical consultation so that 
he or she may make an informed choice. In 
patients who still opt for PTCA, the level of 
surgical support should be heightened. In the 
event of acute vessel closure, every possible mea- 
sure, particularly in the liberal use of IABP 26 or 
even percutaneous cardiopulmonary b pass, must 
be taken in the PTCA suite to attempt o restore 
satisfactory hemodynamic status and reverse isch- 
emia as soon as possible. Then expedient transfer 
of the patient to the operating room for immedi- 
ate revascularization must be carried out. 
Conclusion 
According to the results of emergency revascular- 
ization for PTCA failure in 57 patients, patients with 
MVD are at significantly higher risk for morbidity 
and mortality from a failed PTCA. Patients with 
MVD over 60 years of age with a large proportional 
amount of myocardium at risk may be best served 
by primary surgical revascularization rather than 
PTCA. 
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Discuss ion 
Dr. Frederick L. Grover (Denver, Colo.). Dr. Wang has 
emphasized the increased risk of patients having emer- 
gency CABG after a failed PTCA in a MVD subgroup as 
compared with those patients with SVD. This type of 
analysis is obviously important because the knowledge of 
the risk of a failed PTCA requiring surgical intervention 
must be used in the judgement of the management of
these patients in whom angioplasty isbeing considered as 
a therapeutic option. This information is not only neces- 
sary for the physicians who are recommending the most 
appropriate reatment but also for the patients o they are 
truly signing an informed consent. Dr. Wang has shown a 
significantly higher operative mortality for the MVD 
group as compared with the SVD group, but these num- 
bers are small. Because of the small numbers they must be 
interpreted with caution, Patient risk factors other than 
the number of diseased vessels were similar except for a 
greater incidence of shock and cardiopulmonary resusci- 
tation ahd the decreased ejection fraction in the MVD 
group. 
To determine whether others obtain similar outcomes, 
I reviewed the national Veterans Affairs cardiac surgical 
database and reviewed the data from the New York State 
database courtesy of Dr. Ed Harmon and the Society of 
Thoracic Surgeons database courtesy of Drs. Dick Clark, 
Fred Edwards, and Mark Schwartz. 
In the Veterans Affairs database, 11,474 coronary by- 
pass procedures were performed from 1991 through 1993. 
There were 504 single CABGs, 45 of which were emer- 
gency procedures done within 12 hours of angioplasty with 
an operative mortality of 11.1%. The risk factors other 
than the urgent nature of the procedure and the angio- 
plasty failure were not great, as shown by an estimated 
operative mortality of only 4.9%. Seventy-nine of 10,639 
patients with MVD who underwent emergency CABG 
had an angioplasty procedure within 12 hours of the 
operation with an operative mortality of 16.9%--greater 
than but not statistically significant compared with the 
SVD group mainly because the mortality was also high for 
patients with SVD. This group of patients tended to be at 
higher isk, as shown by an estimated operative mortality 
of 11.1%. An IABP was placed before the operation in 
49.4% of the MVD group as compared with 27% of the 
SVD group, and 14% of the patients with MVD had 
redo procedures compared with only 2.2% of those with 
SVD. 
The New York State database was reviewed for 1993 
and showed that 162 patients with SVD had emergency 
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coronary bypass on the same admission as PTCA with two 
deaths (1.2%), 106 patients with two-vessel disease with 
four deaths (3.7%), and 45 patients with three-vessel 
disease with five deaths (11.1%). 
The Society of Thoracic Surgeons database showed that 
from 1991 to 1993, 3900 patients underwent emergency 
CABG after PTCA with a mortality rate of 3.6% for the 
1289 patients with SVD as compared with 6.5% for the 
2629 patients with MVD. This was significant. 
In conclusion, from review of these databases, although 
there is some variation in how the data are collected in 
terms of the time from failed PTCA to the operation 
among the databases, all of them show a substantial risk 
for patients with MVD undergoing emergency coronary 
bypass after PTCA, and in the Veterans Affairs database 
this also occurs in the SVD group. The authors are 
therefore to be congratulated on bringing this important 
finding to our attention. 
I have a couple of questions that I would like you to 
address if possible. You have shown that age, shock, and 
decreased ejection fraction are univariate predictors of 
poor outcome in these patients in addition to MVD. Was 
there any attempt to stratify or analyze the data according 
to the number of vessels angioplastied. Did you investi- 
gate not only whether it was a left anterior descending 
coronary artery or a right coronary artery but also the 
location within the coronary artery (i.e., proximal coro- 
nary), and the complexity of the lesion in terms of the 
likelihood of this angioplasty failing and resulting in a bad 
surgical outcome? 
Dr. Wang. The data were collected from the PTCA 
registry for the most part, and some of the data were 
collected in a retrospective fashion through patient 
charts. The number of vessels angioplastied and the 
type of Vessel (i.e., left anterior descending versus right 
coronary artery) were not significant factors. Location 
of the lesion (i.e., proximal versus distal) was one 
particular issue that we tried to sort out, but unfortu- 
nately those data were not complete. There were, 
however, certainly more patients with multiple angio- 
plasties in the MVD group. 
Dr. Grover. What  was your use or your cardiologist's 
use of IABP in the cardiac atheterization laboratory and 
would more vigorous use of that entity perhaps result in a 
better surgical outcome? Thank you. 
Dr. Wang. I think you brought up an important point. 
Our cardiologists until recently were not as enthusiastic in
using the IABP in a timely fashion. I think that contrib- 
uted to some of the patients coming to the operating room 
in a basically moribund type of condition. This pattern, 
however, has changed, and IABP is being used much more 
readily. 
Dr. Walter Dembitsky (San Diego, Calif.). In San Diego, 
we have gone one step further. We have actually trained 
nurses and cardiologists to be able to use a portable 
bypass circuit. When there is a problem with hemody- 
namic instability in the catheterization laboratory, pa- 
tients are supported with percutaneous bypass and are 
stabilized so that shock never really develops. Then, an 
attempt is made to open vessels in the catheterization 
laboratory. If the vessels can be opened and the patient is 
still unable to sustain his own circulation, we support him 
for several days more in the intensive care unit and then 
wean him. That has worked very well. If patients do 
require surgical treatment for unopened vessels, we sim- 
ply transfer them to the operating room while supported 
with the bypass machine and then perform the operation 
on that device l~y attaching a cardiotomy to it. That does 
represent a slightly different strategy, and we found it tc 
be successful. I noticed that you did have one patienl 
supported with percutaneous bypass. Are you beginning 
to develop that kind of a program? 
Dr. Wang. We do have percutaneous bypass avail- 
able; however, that particular strategy has been re- 
served for patients who are deemed poor surgiea] 
candidates to begin with. In this particular series, these 
patients in retrospect were fairly good surgical candi- 
dates. The reason some were in such a severely hemo. 
dynamically compromised state was because there was 
large amount of myocardium in jeopardy in the event oJ 
vessel closure, and I think this particular subset ol 
patients perhaps hould be treated ifferently. We hav( 
used percutaneous cardiopulmonary b pass in one pa. 
tient who was in complete arrest, and the balloon pum t
was not able to establish any kind of support. Thi~ 
patient did not survive. 
Dr. Dembitsky. Actually I think that when these pa 
tients are dying, the balloon pump is futile. You probabl! 
agree with that too. 
Dr. Wang. Yes, I agree. 
Dr. Ahmed El Gamel (Manchester, United Kingdom) 
There are two queries in my mind. We have analyzed ou: 
data for 50 cases done as emergencies after failed angio 
plasties, and we found that the time from diagnosis o 
failed angioplasty to the time that the patient underwen 
operation is an important risk factor, and the shorter thi~ 
time period the bett~r the results. I wonder if you have 
found the same thing. 
Also, we have concluded that the use of retrograd~ 
cardioplegia s of paramount importance in this group o 
patients, probably antegrade perfusion would not be ideal 
Has that been a risk factor with your group? 
Dr. Wang. With respect to the second question, we haw 
analyzed the mode of cardioplegia to see whether tha 
adversely affected the postoperative outcome. I thin 
because of the small numbers involved we were not able t~ 
detect a particular difference in outcome. 
Dr. El Gamel. Have you analyzed the anatomic site (i.e 
left anterior descending versus right coronary artery) il 
the outcome of mortality? We think that probably let 
anterior descending SVD is more dangerous angioplast 
failure than right coronary artery disease. 
Dr. Wang. Yes, we have. We looked at the culpri 
vessels involved, and the interesting finding was that th 
circumflex artery was the culprit vessel in only on 
patient. The other patients either had left anterio 
descending or the right coronary artery as the culpri 
vessel. The incidence of the left anterior descendin 
coronary artery being the culprit vessel was twice a 
high as that of the right coronary artery; however, whe: 
we looked in a univariate fashion to see if that i 
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predictive of subsequent outcome, we could not find a 
difference. 
Just to answer your first question, we have not actually 
looked at the amount of ischemic time involved, and I 
think that is part of the weakness of this study in that we 
had to rely on PTCA registry information and that was 
again not available. 
Dr. E1 Gamel. A last point: How many of the patients 
had arterial conduits because we found this unsatisfactory 
in this day and age that you get pressed to perform 
operations in patients who are seriously ill with veins that 
are all unusable with no suitable arterial conduit. We 
think that contributes to the long-term results, and we 
should alert the cardiologists of the importance of check- 
ing on the presence of conduit before attempting some- 
thing like multivessel PTCA. Is that something you have 
noticed as well? 
Dr. Wang. We have always tried to use the internal 
thoracic artery for the left anterior descending target if 
possible. We routinely take the internal thoracic artery 
down after we have established cardiopulmonary b pass 
in these patients. This was possible in about one third of 
the patients. The other two thirds were either in the 
elderly age group or were just not stable enough for 
such an approach. But I do agree with you that these 
were patients in whom the internal thoracic artery was 
not be used because of the emergency situation. 
Appendix A: Variables assessed as predictors of 
morbidity and mortality 
Types of variables 
Demographic 
Age 
Gender 
Weight 
Clinical 
Smoking 
Obesity 
Hypercholesteremia 
Diabetes Mellitus 
Hypertension 
Emphysema 
Prior myocardial infarction 
Ejection fraction 
New York Heart Association class 
PTCA 
Priority--elective vs urgent/emergency 
No. of vessels--single vsmultiple 
Prior PTCA 
Other interventions--stents, a herectomy or laser 
Culprit vessel LAD, RCA or Cx 
Operative 
Preoperative shock 
No. of CABG 
Mode of myocardial protection 
